Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $42.2000 (-2.76%) ($40.1000 - $46.8000) on Mon. Nov. 30, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.02% (three month average) | RSI | 48 | Latest Price | $42.2000(-2.76%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 1.5% a day on average for past five trading days. | Weekly Trend | CAPR advances 2.8% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) SKYY(8%) ARKK(7%) PEJ(7%) VT(7%) XLF(7%) | Factors Impacting CAPR price | CAPR will decline at least -2.01% in a week (0% probabilities). VIXM(-5%) TLT(-5%) GLD(-3%) VCIT(-2%) SLV(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.01% (StdDev 4.02%) | Hourly BBV | 0 () | Intraday Trend | -4.5% | | | |
|
5 Day Moving Average | $43.16(-2.22%) | 10 Day Moving Average | $41.34(2.08%) | 20 Day Moving Average | $41.21(2.4%) | To recent high | -11.3% | To recent low | 9.3% | Market Cap | $831m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |